Zim, SA medical products regulators sign MOU

By Staff Reporter The Medicines Control Authority of Zimbabwe (MCAZ) has signed a Memorandum of Understanding (MoU) with the South African Health Products Regulatory Authority (SAHPRA), allowing the two regulators to develop a cooperative partnership towards ensuring access to safe, quality, and effective health products in the respective countries. This is the second MOU following the signing ceremony between MCAZ and the Egyptian Drug Authority (FDA) last year. MCAZ and SAHPRA will cooperate in joint products reviews and inspections to enable efficient access to health products. This partnership will also…

Read More

MCAZ seizes illegal cough syrups BronCleer and Adco-Salterpyn

The Medicines Control Authority of Zimbabwe (MCAZ) yesterday impounded 450 bottles of cough syrups in Belvedere, Harare. By Kuda Pembere and Nthokozo Gudu The Authority working with CID drugs and narcotics confiscated bottles of BronCleer and Adco-Salterpyn which are unregistered medical products in the country during a raid in the area. After an anonymous tipoff, the Medicines Control Authority of Zimbabwe (MCAZ) has successfully confiscated a total of 450 Bottles of illegal cough syrups (BronCleer and Adco-Salterpyn) during a raid conducted at Old Trafford flats located at 13 Edmond Avenue,…

Read More

MCAZ revokes codeine exporters’ licenses

Some Zimbabwean wholesale pharmaceutical operators had their licenses revoked after the Medicines Control Authority of Zimbabwe (MCAZ) discovered that they were illegally exporting Histalix D, a locally manufactured cough syrup product. to Zambia and Mozambique, By Kuda Pembere Addressing a press conference on Monday MCAZ Head Licencing and Enforcement Division Mrs Caroline Dandira-Samatanga noted that the revokement of licenses or permits was part of its contributions to the fight against drug and substance abuse. “MCAZ’s primary responsibility is to regulate medicines and medical devices in Zimbabwe. Through our robust regulatory…

Read More

Zimbabwe’s Pharmaceutical Industry On Chokehold

High Compliance and regulatory risk, coupled with steep production costs, unending power cuts, and import-related costs for pharmaceutical products and raw materials, have stifled growth in the local pharmaceutical manufacturing and retail sector, Industry players have said. By Michael Gwarisa The high costs of doing business have had a ripple effect on the consumers as the cost of pharmaceutical products locally is beyond the reach of many and in some cases, has led to drug stock-outs as operators struggle to produce and procure pharmaceutical products from source markets. Speaking at…

Read More

MCAZ in Global Benchmarking Tool Maturity Level 3 Upbeat Mode

With the Vice President and Health and Child Care Minister Dr Constantine Chiwenga exhorting the Medicines Control Authority of Zimbabwe (MCAZ) to attain the World Health Organization (WHO) Global Benchmarking Tool (GBT) Maturity Level 3 by year end, the authority says it is well on course as they are now waiting for reassessment. By Kuda Pembere Speaking at the MCAZ Annual General Meeting in Harare on Friday, VP Chiwenga said this GBT is important as it guides regulatory programs of various medical products such as medicines, vaccines, blood products, and…

Read More

MCAZ bans errant pharmaceutical players

THE Medicines Control Authority of Zimbabwe (MCAZ) has barred 16 pharmaceutical operators in the retail and wholesale sectors from operating following a blitz which saw them at fault of different issues such as selling unregistered medicines and failure to account for prescription preparation medicines, HealthTimes has learned. By Kuda Pembere The deviant operators included individuals and premises, and some have been banned from operating till March 2024. Others will have their ban lifted in June 2026. “Medicines Control Authority of Zimbabwe (MCAZ) advises its stakeholders of the cancellation of the…

Read More

MCAZ amends medicine registration requirements

THE Medicines Control Authority of Zimbabwe (MCAZ) recently reviewed the conditions of registration of medicines for better monitoring and analyzing the efficacy as well as the quality of imported and locally manufactured medicines. By Kudakwashe Pembere The Authority which effected this amendment since July 7, 2023, said they are there to ensure that safety, effectiveness and quality of a medicine is maintained throughout its life cycle. This will see applicants having their medicines assessed after every five years in accordance with the current norms and standards. Applicants are required to…

Read More

MCAZ Quality Management Systems charm Rwanda FDA

A delegation of the Rwanda Food and Drug Authority (Rwanda FDA), is in the country to learn and share notes with the Medicines Control Authority of Zimbabwe (MCAZ) quality management systems. By Kuda Pembere The Rwanda FDA Quality Assurance Analyst, Mr Theodene Ndayambaje said MCAZ quality management system is enviable. The Rwanda FDA was established in 2018. I first of all thank you on behalf of RWANDA FDA for the warm welcome. Rwanda FDA having a similar mandate with the MCAZ, and being a new authority established in Rwanda, it…

Read More

MCAZ, Customs, Police, and Prosecting Authority commit to eliminate remarketing of dangerous drugs

THE Medicines Control Authority of Zimbabwe on Friday convened a stakeholder engagement meeting with the Zimbabwe Republic Police (ZRP) Criminal Investigations Department Narcotics Division (CID Narcotics), National Prosecution Authority (NPA)as well as the Zimbabwe Revenue Authority (ZIMRA) where they expressed commitment to eliminate dangerous drugs from the streets. By Kuda Pembere Zimbabwe is seized with the reduction of drug and substance abuse with youths being heavily affected. Speaking after meeting, MCAZ public relations officer Mr Davidson Kaiyo said they agreed on continued collaboration between the stakeholders in law enforcement, judiciary…

Read More

MCAZ warns of fatal skin disease medication side effects

The Medicines Control Authority of Zimbabwe is calling on the public to report to them if they used Isotretinoin and Thalidomide which are specially restricted preparations dangerous enough to cause mental health disorders in children. These drugs are often bought after being prescribed by dermatologists, skin diseases experts. MCAZ Chief Regulation Officer – Enforcement Mrs Caroline Dandira-Samatanga in a statement noted they learned these medical products were widely on sale to the public despite the drugs being prescription drugs. The Medicines Control Authority of Zimbabwe (MCAZ) is mandated to protect…

Read More